Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 20 Key Players companies in Daptomycin
by Highest Patent Value in the China in 2022

The Daptomycin top 20 is Discovery PatSnap’ annual ranking of the top 20 Highest Patent Value Daptomycin Key Players in the China. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2022, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
This medication is an antibiotic used to treat serious bacterial infections.
#
Company Name
Region
Tech Topics
Total
1
Avg patent value: 230,000
2
Avg patent value: 140,000
3
Medicine,Health care,Feed additive,
...[+2]
Avg patent value: 121,166
4
Avg patent value: 120,000
5
Avg patent value: 106,500
6
Avg patent value: 84,800
7
Health care,Research system,International health,
...[+2]
Avg patent value: 84,800
8
Plasma Volume Expander,Antibiotics,Drug,
...[+1]
Avg patent value: 84,800
9
Avg patent value: 76,000
10
Avg patent value: 75,733
11
Drug,Health care,Antineoplastic Drugs,
...[+2]
Avg patent value: 26,760
12
Avg patent value: 21,542
13
Avg patent value: 3,525
14
Avg patent value: 3,400
15
Avg patent value: 3,400
16
Raw material,Simvastatin,Cardiovascular agent,
...[+2]
Avg patent value: 3,400
17
Avg patent value: 3,400
18
Avg patent value: 0
19
Shanghai Fosun Long March Medical Science Co., Ltd.
Avg patent value: 0
20
Avg patent value: 0
Page generation time: Jun 20 2025